ENOV
Enovis Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Enovis Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−12.82%
vs ±11.8% implied · ×1.08
shaded = implied · ▲▼ = realized
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Largest filed tie
0
filed ties
Same SIC code · 6
Same SEC industry code: Intuitive Surgical Inc, Edwards Lifesciences Corp, Steris plc and 3 more; of Enovis Corp's 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Intuitive Surgical Inc, Edwards Lifesciences Corp, Steris plc and 3 more; of Enovis Corp's 6 closest co-movers, none share that code.
No thesis.
Enovis Corp
20.64
pre 20.86 +1.16%
Tall tick = annual report · Source: EDGAR
Expected move
Inputsspot 20.89exp Nov 20ATM strike 20ATM straddle 4.88IV 137%
Bull1
Bear1
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $213.1M | 14.23% | +3.61% |
| American Century Companies | $126.4M | 8.44% | +28.05% |
| Vanguard Portfolioindex-like | $81.3M | 5.43% | +3.09% |
| Rubric | $80.7M | 5.39% | +58.97% |
| UBS | $58.5M | 3.90% | +17.73% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $213.1M | 14.23% | +3.61% |
| American Century Companies | $126.4M | 8.44% | +28.05% |
| Vanguard Portfolioindex-like | $81.3M | 5.43% | +3.09% |
| Rubric | $80.7M | 5.39% | +58.97% |
| UBS | $58.5M | 3.90% | +17.73% |